Detalles de la búsqueda
1.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol
; 98(12): 1856-1868, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772428
2.
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative.
Ann Hematol
; 100(3): 825-830, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409623
3.
Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells.
Biochem Biophys Res Commun
; 520(1): 198-204, 2019 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31585732
4.
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
Haematologica
; 104(11): 2249-2257, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30890600
5.
A catalytically inactive gelatinase B/MMP-9 mutant impairs homing of chronic lymphocytic leukemia cells by altering migration regulatory pathways.
Biochem Biophys Res Commun
; 495(1): 124-130, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29080742
6.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297826
7.
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
Br J Haematol
; 176(4): 618-628, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27977057
8.
PLCG1 mutations in cutaneous T-cell lymphomas.
Blood
; 123(13): 2034-43, 2014 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24497536
9.
A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.
J Biol Chem
; 289(22): 15340-9, 2014 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24739387
10.
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
Br J Haematol
; 169(2): 188-98, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25521006
11.
Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathways.
Biochem Biophys Res Commun
; 461(2): 243-8, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25869069
12.
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.
Blood
; 122(24): 3951-9, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24124086
13.
Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation.
Haematologica
; 105(11): 2655-2658, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131255
14.
Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
Biol Blood Marrow Transplant
; 20(12): 2015-22, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25255162
15.
Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.
Haematologica
; 99(3): 505-10, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24162789
16.
Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis.
Diagnostics (Basel)
; 14(6)2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38535078
17.
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC).
EClinicalMedicine
; 73: 102642, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841711
18.
A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4ß1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.
J Biol Chem
; 287(33): 27601-13, 2012 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22730324
19.
First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group.
Haematologica
; 98(10): 1563-70, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23753021
20.
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study.
Cancers (Basel)
; 15(16)2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627075